Confocal Fluorescence Microscopy Used for Rapid Tissue Evaluation
By LabMedica International staff writers Posted on 16 Apr 2018 |
Image: The Vivascope 2500 confocal scanning microscopic view of lymph node metastases from thyroid carcinoma are papillary structures made up of scanty bright spots floating in a dark background (left) (Photo courtesy of IRCSS Santa Maria Nuova Hospital).
Optical imaging techniques are currently available for imaging tissues without the need for any type of extensive tissue preparation. There are several applications for their potential use in surgical pathology practice.
Unlike in vivo optical imaging, ex vivo optical imaging is not yet routinely used in clinical practice, although several optical imaging modalities are available for ex vivo tissue examination. These techniques include full-field optical coherence tomography, confocal fluorescence microscopy (CFM), and multiphoton microscopy.
Pathology specialists at the University of Texas MD Anderson Cancer Center (Houston, TX, USA) evaluated the feasibility of using a confocal fluorescence microscopy (CFM) platform for ex vivo examination of tissues obtained from surgical resections of breast, lung, kidney, and liver. The team collected fragments of fresh tissue from normal as well as areas of tumor from a total of 55 surgical resections that were performed for malignant tumors of the breast, liver, lung, and kidney soon after completion of immediate intraoperative assessment of the surgical specimen.
The tissue fragments (0.5–1.0 cm) were immersed in 0.6 mM acridine orange for six seconds and imaged using a CFM platform at a 488-nm wavelength. The CFM images of the specimen were obtained using a confocal scanning microscope designed specifically for ex vivo imaging of fresh biologic tissue specimens. The imaged tissues were subsequently fixed in formalin and processed routinely to generate hematoxylin-eosin–stained tissue sections. Mosaics of the grayscale CFM images were studied at different magnifications for recognition of the tissue and were compared with conventional histopathologic examination of hematoxylin-eosin tissue sections.
The scientists imaged 55 tissue fragments obtained from 16 breast (29%), 18 lung (33%), 14 kidney (25%), and seven liver (13%) surgical excision specimens. Acridine orange labeled the nuclei, creating the contrast between nucleus and cytoplasm and thereby recapitulating the tissue architecture. They obtained CFM images of good quality within 5 to 10 minutes that allowed recognition of the cytomorphologic details for categorization of the imaged tissue and were similar to histologic examination of hematoxylin-eosin tissue sections.
The authors concluded that the relative ease and speed of grayscale image acquisition together with the quality of images that were obtained with the CFM platform used in their study suggest that this technique has promise for use in surgical pathology practice. The CFM images are similar to H&E images and the use of this CFM technique for possible applications in surgical pathology, such as rapid evaluation of specimen adequacy of core needle biopsy at the time of procurement, margin evaluation of surgical resection specimens, and quality assurance of the tissues for biobanking, needs serious consideration. The study was published in the March 2018 issue of the journal Archives Of Pathology & Laboratory Medicine.
Related Links:
University of Texas MD Anderson Cancer Center
Unlike in vivo optical imaging, ex vivo optical imaging is not yet routinely used in clinical practice, although several optical imaging modalities are available for ex vivo tissue examination. These techniques include full-field optical coherence tomography, confocal fluorescence microscopy (CFM), and multiphoton microscopy.
Pathology specialists at the University of Texas MD Anderson Cancer Center (Houston, TX, USA) evaluated the feasibility of using a confocal fluorescence microscopy (CFM) platform for ex vivo examination of tissues obtained from surgical resections of breast, lung, kidney, and liver. The team collected fragments of fresh tissue from normal as well as areas of tumor from a total of 55 surgical resections that were performed for malignant tumors of the breast, liver, lung, and kidney soon after completion of immediate intraoperative assessment of the surgical specimen.
The tissue fragments (0.5–1.0 cm) were immersed in 0.6 mM acridine orange for six seconds and imaged using a CFM platform at a 488-nm wavelength. The CFM images of the specimen were obtained using a confocal scanning microscope designed specifically for ex vivo imaging of fresh biologic tissue specimens. The imaged tissues were subsequently fixed in formalin and processed routinely to generate hematoxylin-eosin–stained tissue sections. Mosaics of the grayscale CFM images were studied at different magnifications for recognition of the tissue and were compared with conventional histopathologic examination of hematoxylin-eosin tissue sections.
The scientists imaged 55 tissue fragments obtained from 16 breast (29%), 18 lung (33%), 14 kidney (25%), and seven liver (13%) surgical excision specimens. Acridine orange labeled the nuclei, creating the contrast between nucleus and cytoplasm and thereby recapitulating the tissue architecture. They obtained CFM images of good quality within 5 to 10 minutes that allowed recognition of the cytomorphologic details for categorization of the imaged tissue and were similar to histologic examination of hematoxylin-eosin tissue sections.
The authors concluded that the relative ease and speed of grayscale image acquisition together with the quality of images that were obtained with the CFM platform used in their study suggest that this technique has promise for use in surgical pathology practice. The CFM images are similar to H&E images and the use of this CFM technique for possible applications in surgical pathology, such as rapid evaluation of specimen adequacy of core needle biopsy at the time of procurement, margin evaluation of surgical resection specimens, and quality assurance of the tissues for biobanking, needs serious consideration. The study was published in the March 2018 issue of the journal Archives Of Pathology & Laboratory Medicine.
Related Links:
University of Texas MD Anderson Cancer Center
Latest Pathology News
- Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization
- First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests
- AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis
- New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance
- New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis
- Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse
- Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection
- Image-Based AI Shows Promise for Parasite Detection in Digitized Stool Samples
- Deep Learning Powered AI Algorithms Improve Skin Cancer Diagnostic Accuracy
- Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities
- Virtual Skin Biopsy Determines Presence of Cancerous Cells
- AI Detects Viable Tumor Cells for Accurate Bone Cancer Prognoses Post Chemotherapy
- First Ever Technique Identifies Single Cancer Cells in Blood for Targeted Treatments
- Innovative Blood Collection Device Overcomes Common Obstacles Related to Phlebotomy
- Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes
- Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases